The Occurrence of Reactions and Impairments in Leprosy: Experience in the Leprosy Control Program of Three Provinces in Northeastern Thailand, 1978-1995. II. Reactions

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 66, Issue 2, 1998, Pages 159-169

  Schreuder, Pieter A M ^a,b  

^a Leprosy Control Center Region 6   (Thailand)

^b East Java Leprosy Control Project   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHEMA NODOSUM; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION CONTROL; LEPROSY; MAJOR CLINICAL STUDY; PREVALENCE; RECURRENT DISEASE; THAILAND;

COHORT STUDIES; HUMANS; INCIDENCE; LEPROSY; PERIPHERAL NERVOUS SYSTEM DISEASES; RECURRENCE; RISK FACTORS; THAILAND; TIME FACTORS;

EID: 0031774846     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. BECX-BLEUMINK, M. Relapses among leprosy patients treated with multidrug therapy: experience in the Leprosy Control Program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia: practical difficulties with diagnosing relapses, operational procedures and criteria for diagnosing relapses. Int. J. Lepr. 60 (1992) 421-435.
2. BECX-BLEUMINK, M. and BERHE, D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy: experience in the Leprosy Control Program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int. J. Lepr. 60 (1992) 173-184.
3. BECX-BLEUMINK, M., BERHE, D. and 'T. MANNETJE, W. The management of nerve damage in the leprosy control services. Lepr. Rev. 61 (1990) 1-11.
4. BERNINK, E. H. M. and VOSKENS, J. E. Study on the detection of leprosy reactions and the effect of prednisone on various nerves, Indonesia. Lepr. Rev. 68 (1997) 225-232.
5. BOERRIGTER, G., PONNIGHAUS, J. M. and FINE, P. E. M. Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi. Int. J. Lepr. 56 (1988) 408-417.
6. BOERRIGTER, G., PONNIGHAUS, J. M., FINE, P. E. M. and WILSON, R. J. Four-years follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi. Int. J. Lepr. 59 (1991) 255-261.
7. BWIRE, R. and KAWUMA, H. J. S. Hospital-based epidemiological study of reactions, Buluba Hospital, 1985-89. Lepr. Rev. 64 (1993) 325-329.
8. DASANANJALI, K., SCHREUDER, P. A. M. and PIRAYAVARAPORN, C. A study of the effectiveness and safety of the WHO MDT regimen in the northeast of Thailand, a prospective study, 1984-1996. Int. J. Lepr. 65 (1997) 28-36.
9. DE RIJK, A., GABRE, S., BYASS, P. and BERHANU, T. Field evaluation of WHO MDT fixed duration at ALERT, Ethiopia: the AMFES project - II. Reaction and neuritis during and after MDT in PB and MB leprosy. Lepr. Rev. 65 (1994) 320-332.
10. GROENEN, G., JANSSENS, L., KAYEMBE, T., NOLLET, E., COUSSENS, L. and PATTYN, S. R. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions. Int. J. Lepr. 54 (1986) 236-244.
11. KATOCH, K., RAMANATHAN, U., NATRAJAN, M., BAGGA, A. K., BHATIA, A. S., SAXENA, R. K. and RAMU, G. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. Int. J. Lepr. 57 (1989) 458-464.
12. KIRKWOOD, B. R. Essentials of Medical Statistics. Oxford: Blackwell Scientific, 1988.
13. LIENHARDT, C. and FINE, P. E. M. Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr. Rev. 65 (1994) 190-203.
14. LOCKWOOD, D. N. J., VINAYAKUMAR, S., STANLEY, J. N. A., MCADAM, P. W. J. and COLSTON, M. J. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int. J. Lepr. 61 (1993) 8-15.
15. NAAFS, B. Treatment of reactions and nerve damage. Int. J. Lepr. 64 Suppl. (1996) s21-s28.
16. NAAFS, B., MADOMBI, L., MATEMERA, B. O. and ELLIS, B. P. B. Short-term WHO advised multiple drug treatment of paucibacillary leprosy patients. Indian J. Lepr. 58 (1986) 348-353.
17. NAAFS, B., PEARSON, J. and WHEATE, H. Reversal reaction: the prevention of permanent nerve damage. Comparison of short- and long-term steroid treatment. Int. J. Lepr. 47 (1979) 7-12.
18. PEARSON, J. The use of corticosteroids in leprosy. Lepr. Rev. 52 (1981) 293-298.
19. PONNIGHAUS, J. M. and BOERRIGTER, G. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi. Int. J. Lepr. 63 (1995) 1-7.
20. PONNIGHAUS, I. M., BOERRIGTER, G., FINE, P. E. M., PÖNNIGHAUS, J. M. and RUSSELL, J. Disabilities in leprosy patients ascertained in a total population survey in Karonga District, northern Malawi. Lepr Rev. 61 (1990) 366-374.
21. POST, E., CHIN-A-LIEN, R. A M., BOUMAN, C., NAAFS, B. and FABER, W. R. Leprosy in The Netherlands in the period 1970-1991. Ned. Tijdschr. Geneeskd. 138 (1994) 1960-1963.
22. RICHARDUS, J. H.. FINLAY, K. M., CROFT, R. P. and SMITH, W. C S. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh. Lepr. Rev. 67 (1996) 297-305.
23. RIDLEY, D. S. Reactions in leprosy. Lepr. Rev. 40 (1969) 77-81.
24. ROCHE, P. W., THEUVENET, W. J. and BRITTON, W. J. Risk factors for type-1 reactions in borderline leprosy patients. Lancet 338 (1991) 654-657.
25. ROSE, P. and WATERS, M. Reversal reactions in leprosy and their management. Lepr. Rev. 62 (1992) 113-121.
26. SCOLLARD, D. M., SMITH, T., BHOOPAT, L., THEETRANONT, C., RANGDAENG, S. and MORENS, D. M. Epidemiologic characteristics of leprosy reactions. Int. J. Lepr. 62 (1994) 559-567.
27. SUGUMARAM, D. S. T. Steroid therapy for paralytic deformities in leprosy. Int. J. Lepr. 65 (1997) 337-344.
28. VAN BRAKEL, W. H. and KHAWAS, I. B. Silent neuropathy in leprosy: an epidemiological description. Lepr. Rev. 65 (1994) 350-360.
29. VAN BRAKEL, W. H. and KHAWAS, I. B. Nerve damage in leprosy: an epidemiological study of 396 patients in west Nepal - part 1. Definitions, methods and frequencies. Lepr. Rev. 65 (1994) 204-221.
30. VAN BRAKEL, W. H., KHAWAS, I B. and LUCAS, S. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal. Lepr. Rev. 65 (1994) 190-203.
31. VIJAYAKUMARAN, V., MANIMOZHI, N. and JESUDASAN, K. Incidence of late lepra reaction among multibacillary leprosy after MDT. Int. J. Lepr. 63 (1995) 18-22.
32. WATSON, J. M. Essential Action to Minimise Disability in Leprosy Patients. London: The Leprosy Mission, 1986.
33. WORLD HEALTH ORGANIZATION. A guide to leprosy control. 2nd edn. Geneva: World Health Organization, 1988.